Stay updated on Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page.

Latest updates to the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows Revision: v3.4.2 and removes the funding/operating status notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide funding notice was added. The page revision shows version v3.4.1 replacing v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedGlossary has been added to the page to help users understand terms used in the study record. The page now shows new labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the older variants 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, representing a platform version update with no substantive changes to the study page. No study data, eligibility criteria, or results were modified.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a consolidated 'Locations' section listing sites in CA, GA, IL, OR, PA, and TN and removed the separate 'California Locations', 'Georgia Locations', 'Illinois Locations', 'Oregon Locations', 'Pennsylvania Locations', and 'Tennessee Locations' headers. Revision updated to v3.3.3.SummaryDifference0.6%

- Check92 days agoChange DetectedRevision: v3.3.2 added and Revision: v3.2.0 removed, likely representing backend version updates rather than changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page.